Literature DB >> 19496747

Recent developments of biodegradable and biocompatible materials based micro/nanoparticles for delivering macromolecular therapeutics.

Yang Shi1, Guihua Huang.   

Abstract

Developments in biotechnology have seen the growing use of macromolecules containing proteins, peptides, vaccines, antigens, genes, and growth factors as therapeutic agents. Because these macromolecules are easily denatured and metabolized rapidly in vivo, their protection and controlled release are required. Biodegradable and biocompatible materials based micro/nanoparticles (MPs/NPs) show great potential for delivering macromolecular therapeutics. One of the greatest challenges in the delivery of macromolecules from biodegradable and biocompatible MPs/NPs is the controlled and complete release of the drugs in their native forms. Unfortunately, the present drug delivery systems cannot satisfy the requirement; thus, more research is expected. This article discusses the recent developments in the field of macromolecular delivery.

Mesh:

Substances:

Year:  2009        PMID: 19496747     DOI: 10.1615/critrevtherdrugcarriersyst.v26.i1.20

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  10 in total

Review 1.  Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.

Authors:  Benjamin G Keselowsky; Chang Qing Xia; Michael Clare-Salzler
Journal:  Hum Vaccin       Date:  2011-01-01

Review 2.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 3.  Nanoparticulate RNA delivery systems in cancer.

Authors:  Ankur Sharma; Niraj Kumar Jha; Kajal Dahiya; Vivek Kumar Singh; Kundan Chaurasiya; Aditya Narayan Jha; Saurabh Kumar Jha; Prabhu Chandra Mishra; Sunny Dholpuria; Rani Astya; Parma Nand; Amit Kumar; Janne Ruokolainen; Kavindra Kumar Kesari
Journal:  Cancer Rep (Hoboken)       Date:  2020-07-30

Review 4.  Recent advances in oral vaccine development: yeast-derived β-glucan particles.

Authors:  Rebecca De Smet; Liesbeth Allais; Claude A Cuvelier
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

5.  Biomaterials that regulate growth factor activity via bioinspired interactions.

Authors:  Gregory A Hudalla; William L Murphy
Journal:  Adv Funct Mater       Date:  2011-05-24       Impact factor: 18.808

6.  Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells.

Authors:  Saurabh Dixit; Rajnish Sahu; Richa Verma; Skyla Duncan; Guillermo H Giambartolomei; Shree R Singh; Vida A Dennis
Journal:  Biomaterials       Date:  2017-12-26       Impact factor: 12.479

Review 7.  Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications.

Authors:  Wei Ji; Yan Sun; Fang Yang; Jeroen J J P van den Beucken; Mingwen Fan; Zhi Chen; John A Jansen
Journal:  Pharm Res       Date:  2010-11-19       Impact factor: 4.200

8.  Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo.

Authors:  Li Luo; Tao Qin; Yifan Huang; Sisi Zheng; Ruonan Bo; Zhenguang Liu; Jie Xing; Yuanliang Hu; Jiaguo Liu; Deyun Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model.

Authors:  Nao Nakajima; Satoru Hashimoto; Hiroki Sato; Kazuya Takahashi; Takuro Nagoya; Kenya Kamimura; Atsunori Tsuchiya; Junji Yokoyama; Yuichi Sato; Hanako Wakatsuki; Masayuki Miyata; Yusuke Akashi; Ryusuke Tanaka; Ken Matsuda; Yasuhiko Tabata; Shuji Terai
Journal:  Regen Ther       Date:  2019-05-10       Impact factor: 3.419

Review 10.  Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections.

Authors:  Yuye Wu; Dheerendranath Battalapalli; Mohammed J Hakeem; Venkatarao Selamneni; Pengfei Zhang; Mohamed S Draz; Zhi Ruan
Journal:  J Nanobiotechnology       Date:  2021-12-04       Impact factor: 10.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.